VP, Kymab Technology and Research
E-Chiang was appointed VP, Technology and Research in September 2021 having joined Kymab as a founding scientist in 2010. E-Chiang is an inventor on several of Kymab’s IntelliSelect Transgenics platforms, including the Common-light-chain bi-specific platform.
E-Chiang previously worked at Lexicon Pharmaceuticals focusing on target discovery and early development of therapeutic antibodies. E-Chiang completed his postdoctoral training at National Cancer Institute US and invented the recombineering technology used for large genetic engineering. E-Chiang received his PhD in Molecular Genetics from Albert Einstein College of Medicine. E-Chiang is an inventor of more than 110 granted patents.